Head-to-head · WeighScore
PepHaūs vs Science & Co
By GLP-1 ScorecardUpdated
Score comparison
PepHaūs has the higher recorded score — 82.7/100 to 72.9/100.
PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Verified and nationwide, but priced in the upper-mid band ($152/$246).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | PepHaūs | Science & Co |
|---|---|---|
| WeighScore | 82.7/100 | 72.9/100 |
| Grade | B− | C |
| Site position | #27 | #84 |
| Semaglutide | $152/mo | $149/mo month-to-month ($79 only on a 12-month plan) |
| Tirzepatide | $246/mo | $199/mo month-to-month ($125 only on a 12-month plan) |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #27 · B−
Strengths
- LegitScript-verified, all 50 states
- Both molecules
- Transparent listed pricing
What to consider
- Upper-mid pricing ($152/$246)
- Injection-only
- Monitoring detail limited
Site position #84 · C
Strengths
- States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
- Its own FAQ names the commitment behind the headline: "Plans start at $125 a month on the 12 month plan"
- The printed saving corroborates the reference price — 125 divided by 199 is 63%, exactly the "Save 37%" shown
- "Same Price, Any Dose", with no hidden fees, no monthly membership and free shipping stated in the FAQ
- Names its operating entity and state of incorporation, and says every batch is third-party tested
What to consider
- The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
- Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
- It says it is not a compounding facility but never names the pharmacy that is
- No lab or monitoring protocol is published
- Injection only on the pages read — no oral route and no brand lane
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.